Module Database Search


Module Title
Therapeutics

Keywords
clinical pharmacology, pathophysiology, evidence based therapeutics, drug therapy selection, patient and drug factors influencing selection, monitoring

ReferencePHM020
SCQF LevelSCQF 11
SCQF Points5
ECTS Points2.5
CreatedApril 2003
ApprovedJune 2003
AmendedJune 2007
Version No.3

Prerequisites for Module

None in addition to course entry requirements or in consultation with the Course Leader.

Corequisite Modules

None.

Precluded Modules

None.

Aims of Module

To develop professional competence in the therapeutics of (refer to Note 1 in Additional Notes) with emphasis on rational prescribing.

Learning Outcomes for Module

On completion of this module, students are expected to be able to:

1. Demonstrate by application a comprehensive, detailed understanding of pathophysiology, clinical pharmacology and evidence based therapeutics for the specified disorders.
2. Interpret a variety of types of numerical data, including biochemical, haematological, and pharmacokinetic parameters, to aid drug selection and monitoring for individual patients.
3. Critically evaluate patient data to solve therapeutic problems, select and monitor drug therapy for individual patients.
4. Reflect on available information, formulate advice for patients and health care professionals.

Indicative Module Content

Pathophysiology, natural history and progression of conditions (refer to Note 1 in Additional Notes. Evidence based therapeutics and clinical pharmacology of drugs used to treat conditions (refer to Note 1 in Additional Notes). Use of patient data, including physical examination, physiological, biochemical and haematological parameters, to select, optimise and monitor drug therapy for conditions (refer to Note 1 in Additional Notes. Selection of therapy, factors influencing prescribing decisions including patients characteristics (elderly, young, pregnant/breast feeding mothers, ethnic origin and co-morbidities), and drug factors (adverse drug reactions, drug interactions), aspects of pharmacokinetics/ pharmacodynamics. Management options including non-drug treatment. Formulation of advice for patients and health care professionals for conditions (refer to Note 1 in Additional Notes).

Indicative Student Workload

Directed Study

Distance Learning
Assessments
3
Directed reading
20
Self-assessment
17

Private Study

 

10

Mode of Delivery

The module is delivered in distance learning mode by self-directed learning from web based learning materials including self-assessment questions with feedback.

Assessment Plan

Learning Outcomes Assessed
Component 1 1,2,3,4

Component 1 will be assessed through critical analysis of a case study in different therapeutic areas and submission of a patient profile document.

Indicative Bibliography

1.Haslett, C., Chilvers, E., Boon, N., Colledge, N., Hunter, J., eds. Davidson's Principles and Practice of Medicine. Current edition. London: Churchill Livingston.
2.British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary. Current edition. London: BMJ Publishing Group.

Additional Notes

1. This module is studied in the context of a selection of the seven different therapeutic areas below:
Cardiovascular 1 - hypertension, congestive cardiac failure and atrial fibrillation.
Cardiovascular 2 - stroke, ischaemic heart disease and hyperlipidaemia.
Respiratory - asthma and chronic obstructive pulmonary disease.
Endocrine - thyroid dysfunction, diabetes mellitus, contraception and hormone replacement therapy.
Musculoskeletal - gout, osteoarthritis, rheumatoid arthritis and osteoporosis.
Gastrointestinal - peptic ulcer disease, gastro-oesophageal reflux disease and inflammatory bowel disease.
Infections - urinary tract, respiratory, fungal and viral infections and antimicrobial resistance policies and guidelines associated with the management and treatment of infections.


Robert Gordon University, Garthdee House, Aberdeen, AB10 7QB, Scotland, UK: a Scottish charity, registration No. SC013781